Ai

(Image: Getty/Tampatra)

Year begins with bang for AI drug development

By Ben Hargreaves

Alongside the first drug developed by AI entering clinical trials, there have been a number of other instances of the technology being used to aid the discovery of new treatments.

(Image: Getty/Andy)

Funding for AI startups dries up

By Ben Hargreaves

The number of startup companies emerging and the funding that they received took a sharp downturn in 2019.

(Image: Getty/chombosan)

FT PHARMACEUTICAL & BIOTECHNOLOGY CONFERENCE

The danger of ‘going too far’ with AI

By Vassia Barba

Industry experts dealing with AI services should be showing both devotion to the possibilities opened and skepticism at the same time, says ICON exec.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers